SEC Insider Transactions from Stephens Kristin.

Last updated: 2026-03-14 10:48 UTC | Total transactions: 9

Stephens Kristin has filed 9 insider transactions across 1 company since March 2024.

Most recent transaction: a sale of 36133 shares of Syros Pharmaceuticals, Inc. ($SYRS) on November 18, 2024.

Activity breakdown: 0 open-market purchases and 1 sale.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Nov. 18, 2024 Syros Pharmaceuticals, Inc. $SYRS Stephens Kristin Chief Development Officer S Common Stock 36133 $0.22 0.0000 39,335,772 100.00% 0.09%
Oct. 31, 2024 Syros Pharmaceuticals, Inc. $SYRS Stephens Kristin Chief Development Officer M Common Stock 17000 $0.00 42,237.0000 39,335,772 67.36% 0.04%
Oct. 31, 2024 Syros Pharmaceuticals, Inc. $SYRS Stephens Kristin Chief Development Officer F Common Stock 6104 $2.09 36,133.0000 39,335,772 14.45% 0.02%
Oct. 31, 2024 Syros Pharmaceuticals, Inc. $SYRS Stephens Kristin Chief Development Officer M Restricted Stock Units 17000 $0.00 0.0000 39,335,772 100.00% 0.04%
March 31, 2024 Syros Pharmaceuticals, Inc. $SYRS Stephens Kristin Chief Development Officer M Common Stock 2000 $0.00 17,789.0000 28,325,779 12.67% 0.01%
March 31, 2024 Syros Pharmaceuticals, Inc. $SYRS Stephens Kristin Chief Development Officer M Common Stock 11666 $0.00 29,455.0000 28,325,779 65.58% 0.04%
April 1, 2024 Syros Pharmaceuticals, Inc. $SYRS Stephens Kristin Chief Development Officer F Common Stock 4218 $5.12 25,237.0000 28,325,779 14.32% 0.01%
March 31, 2024 Syros Pharmaceuticals, Inc. $SYRS Stephens Kristin Chief Development Officer M Restricted Stock Units 2000 $0.00 4,000.0000 28,325,779 33.33% 0.01%
March 31, 2024 Syros Pharmaceuticals, Inc. $SYRS Stephens Kristin Chief Development Officer M Restricted Stock Units 11666 $0.00 23,334.0000 28,325,779 33.33% 0.04%